isatin has been researched along with cytochrome c-t in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baraldi, PG; Bermejo, J; Cruz-Lopez, O; Estévez, F; Preti, D; Romagnoli, R | 1 |
| Ge, Y; Hou, L; Ju, C; Song, J; Yue, W; Zhang, J | 1 |
2 other study(ies) available for isatin and cytochrome c-t
| Article | Year |
|---|---|
alpha-Bromoacrylamido N-substituted isatin derivatives as potent inducers of apoptosis in human myeloid leukemia cells.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cytochromes c; Enzyme Activation; HL-60 Cells; Humans; Isatin; Leukemia, Promyelocytic, Acute; Molecular Structure; Poly(ADP-ribose) Polymerases; U937 Cells | 2009 |
Isatin inhibits proliferation and induces apoptosis of SH-SY5Y neuroblastoma cells in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Proliferation; Cytochromes c; Female; Humans; Isatin; Mice; Mice, Nude; Neuroblastoma; Proto-Oncogene Proteins c-bcl-2; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |